That didn’t take long. Less than a week after Pfizer was hit with a lawsuit over a fellowship program that excludes whites and Asians, shareholders are demanding that the company scrap a spate of race-conscious policies that they say put it at risk of further litigation.
The lawsuit, filed Sept. 15, argues that Pfizer is violating federal law by excluding white and Asian applicants from its prestigious “Breakthrough Fellowship.” In an open letter to Pfizer executives last week, shareholders allege that the program is just one of several policies that invite a “pandora’s box” of civil rights complaints.
Read more on the Washington Free Beacon.
Get up to speed with the threats facing healthcare – and how we’re protecting patients and physicians.
"*" indicates required fields